| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/08/2007 | CA2617049A1 Compounds and methods for the treatment of cancer |
| 03/07/2007 | EP1760090A1 Regulatory/unfolding peptides of ezrin |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1760082A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1759708A1 IFN-beta for treating bone disorder related to cancer |
| 03/07/2007 | EP1759699A1 Liposome preparation containing slightly water-soluble camptothecin |
| 03/07/2007 | EP1759696A1 Antineoplastic cocoa extracts, methods for making, using |
| 03/07/2007 | EP1759694A2 Combinations of DMXAA and other anti-cancer agents |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758935A1 High affinity telomerase t cell receptors |
| 03/07/2007 | EP1758931A1 Peptides derived from decorin leucine rich repeats and uses thereof |
| 03/07/2007 | EP1758926A2 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 03/07/2007 | EP1758904A1 Flavopereirine derivatives for cancer therapy |
| 03/07/2007 | EP1758895A1 Gonadotropin releasing hormone receptor antagonists |
| 03/07/2007 | EP1758887A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 03/07/2007 | EP1758881A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 03/07/2007 | EP1758880A1 Hydroxamates, their manufacture and use as pharmaceutical agents |
| 03/07/2007 | EP1758872A1 Process for the preparation of anastrozole |
| 03/07/2007 | EP1758655A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| 03/07/2007 | EP1758610A1 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 03/07/2007 | EP1758602A1 Pharmaceutical active substance extracted from lycosa tarantula |
| 03/07/2007 | EP1758601A1 Treatment with cisplatin and an egfr-inhibitor |
| 03/07/2007 | EP1758593A1 Vascular damaging agents for administration as an intravenous infusion |
| 03/07/2007 | EP1758592A1 Treatment of cancer in pediatric patients |
| 03/07/2007 | EP1758573A1 A pharmaceutical composition and its use |
| 03/07/2007 | EP1758453A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 03/07/2007 | EP1531842A4 Regulation of cell growth by muc1 |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1478355B1 Antitumor compositions containing taxane derivatives |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1327149A4 Methods of high-throughput screening for internalizing antibodies |
| 03/07/2007 | EP1279677B1 Gd3-mimetic peptides |
| 03/07/2007 | EP1228202B1 Antisense compositions and cancer-treatment methods |
| 03/07/2007 | EP1220678B1 Pharmaceutical compositions containing copper, salicylic acid and vitamin c |
| 03/07/2007 | EP1131348B1 Regulatory/unfolding peptides of ezrin |
| 03/07/2007 | EP1044013B1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 03/07/2007 | EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS |
| 03/07/2007 | EP1017817B1 Mutants of thyroid stimulating hormone |
| 03/07/2007 | EP0838221B1 Lyophilized hgf preparations |
| 03/07/2007 | CN1926137A Pyrrole-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926133A Epothilone derivatives |
| 03/07/2007 | CN1926132A Pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2007 | CN1926128A Dipeptidyl peptidase inhibitors |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1924021A Gene recombination humanized pigment epithelium derivative factor and application therof |
| 03/07/2007 | CN1924015A Important regulation albumen ChK2 of NF-KB signal path |
| 03/07/2007 | CN1924014A Interference RNA sequence of specificity interference MTA1 mRNA for inhibiting tumor metastasis |
| 03/07/2007 | CN1924006A Anti-glioma peptide of scorpion, preparation method and application thereof |
| 03/07/2007 | CN1923837A Lipophilic platinum antineoplastic complex |
| 03/07/2007 | CN1923827A Eremophilone lactones acid natural product and application thereof |
| 03/07/2007 | CN1923825A Novel antibiotic Chemomycin A and preparation method thereof |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923791A Preparation method of Suillin and application thereof |
| 03/07/2007 | CN1923784A 4,5-ringopening diterpene quinine analogue and use thereof |
| 03/07/2007 | CN1923286A Anticancer slow release agent of anticancer antibiotics and its progression agent |
| 03/07/2007 | CN1923284A Anti-cancer drug slow release injection and uses thereof |
| 03/07/2007 | CN1923283A Anti-cancer drug slow release injection and uses thereof |
| 03/07/2007 | CN1923282A Anti-cancer slow release injection comprising hormone drug |
| 03/07/2007 | CN1923281A Anti-cancer slow release injection comprising plant alkaloid |
| 03/07/2007 | CN1923280A Anti-cancer slow release injection containing dichloroethylaminum |
| 03/07/2007 | CN1923276A Important regulation protein PAK7 of NF[kappa]B signal path |
| 03/07/2007 | CN1923248A Five-poison medicine for treating tumor |
| 03/07/2007 | CN1923247A Plant medicine for eliminating cancer pain drastically and curing late cancers |
| 03/07/2007 | CN1923232A Medicine composition for dispersing pathogenic wind and extinguishing phlegm, absorbing clots and softening hard masses, preparation method and use thereof |
| 03/07/2007 | CN1923223A Preparing method and application of nano shen-qi-fu-zheng injectio |
| 03/07/2007 | CN1923212A Application of paris polyphyla var. yunnanensis stem and leaf monomer saponin in pharmaceutical industry |
| 03/07/2007 | CN1923208A Preparation method and medical use of trichinellidae nematodes immune ribonucleic acid |
| 03/07/2007 | CN1923197A Freeze-dried temzolomide powder for injection and its preparing process |
| 03/07/2007 | CN1923192A Application of arteannuin and derivative thereof as clinical anticancer drug and dosage forms thereof |
| 03/07/2007 | CN1923190A Curcumenol intralipid for injecta and its preparation process |
| 03/07/2007 | CN1923189A Taxine kind anti-cancer slow release injection |
| 03/07/2007 | CN1923176A Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 03/07/2007 | CN1923175A Slow release injection comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923173A Anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923172A Drug slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923171A Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923167A Slow release injection and its preparing process and application |
| 03/07/2007 | CN1303105C Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application |
| 03/07/2007 | CN1303099C Ganoderma tsugae-proteoglycan mixture and its preparing method and use |
| 03/07/2007 | CN1303098C Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine |
| 03/07/2007 | CN1303090C Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303046C Production process for picking-up against cancer pharmaceutical product of beta element from Curcuma |
| 03/07/2007 | CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 03/07/2007 | CN1302809C Nanometer granule prepn of bufanin albumin and its prepn process |
| 03/07/2007 | CN1302808C Nanometer granule prepn of cinobufagin toxoprotein and its prepn process |
| 03/07/2007 | CN1302801C Compound traditional Chinese medicine formulation for curing hysteromyoma |
| 03/07/2007 | CN1302797C Antineoplastic vascular embolic agent and its preparing process |
| 03/07/2007 | CN1302782C Jixitabing hydrochloride solution type injection agent |
| 03/07/2007 | CN1302781C Target magnetic nano drug for treating leucosis and producing method thereof |
| 03/07/2007 | CN1302780C Use of alkyl phosphocholines in preparation of medicine used with antitumor medicaments |
| 03/07/2007 | CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |